Eurobio Scientific Completes Acquisition of Voden Medical Instruments' Life Sciences Unit
Deal News | Jul 01, 2025 | Globenewswire
Eurobio Scientific, a leading French group specializing in in-vitro medical diagnostics and life sciences, has announced the completion of its acquisition of the Life Sciences unit of Voden Medical Instruments Spa in Italy as of July 1, 2025. This unit specializes in diagnostics, cell and molecular biology, and genome analysis. With the acquisition, Eurobio Scientific will strengthen its operations in Italy and enhance the commercial distribution of its proprietary products. The transaction is entirely cash-financed through the company's cash reserves and a bank loan. Eurobio Scientific is a significant player with a diverse portfolio in transplantation, immunology, and infectious diseases diagnostics, supplying to both research labs and the pharmaceutical and biotech sectors. The group boasts a global presence with production units in several countries and a robust distribution network. Eurobio Scientific's primary shareholders include EB Development in partnership with funds managed by NextStage AM and IK Partners.
Sectors
- Diagnostics and Medical Devices
- Biotechnology
- Healthcare Services
Geography
- France – Eurobio Scientific is headquartered in France.
- Italy – The acquisition of Voden Medical Instruments' Life Sciences unit is directly linked to Eurobio Scientific's expansion in the Italian market.
- Europe – The transaction indicates an extended European operational presence, with Eurobio Scientific and the acquired entity located in European countries.
Industry
- Diagnostics and Medical Devices – The article focuses on Eurobio Scientific's operations in the diagnostics field, particularly involving the acquisition of a diagnostic-centered unit.
- Biotechnology – Eurobio Scientific and the acquired unit both operate significantly within the biotechnology sector, focusing on cell and molecular biology and genome analysis.
- Healthcare Services – The acquisition pertains to life sciences and healthcare services, expanding Eurobio Scientific's footprint in the Italian healthcare market.
Financials
- Not Disclosed – The financial terms of the acquisition were not disclosed at the request of the seller.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Eurobio Scientific | Acquiring Company | Company | A leading French company specializing in in-vitro medical diagnostics and life sciences. |
| Voden Medical Instruments Spa | Target Company | Company | An Italian firm whose Life Sciences unit specializes in diagnostics, cell and molecular biology, and genome analysis. |
| EB Development | Shareholder | Company | A major shareholder of Eurobio Scientific, working with NextStage AM and IK Partners. |
| NextStage AM | Investment Fund | Company | Manages funds associated with Eurobio Scientific's shareholder structure. |
| IK Partners | Investment Fund | Company | Manages funds associated with Eurobio Scientific's shareholder structure. |